Struggling to find Tenofovir Alafenamide (Vemlidy) at your pharmacy? Learn why this hepatitis B medication is hard to find in 2026 and what you can do.
You've been prescribed Tenofovir Alafenamide — sold under the brand name Vemlidy — and your pharmacy tells you it's out of stock. Or maybe they can't even order it. If this sounds familiar, you're not alone. Thousands of patients across the country who rely on this hepatitis B medication have faced the same frustrating experience.
In this post, we'll explain exactly what Tenofovir Alafenamide is, why it can be so difficult to find in 2026, and — most importantly — what steps you can take right now to get your prescription filled.
Tenofovir Alafenamide (often abbreviated as TAF) is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and children ages 6 and older who weigh at least 25 kg. It's manufactured by Gilead Sciences and sold under the brand name Vemlidy.
TAF belongs to a class of drugs called nucleotide reverse transcriptase inhibitors (NtRTIs). It works by blocking the hepatitis B virus from replicating inside your body. Specifically, it's a prodrug of tenofovir — meaning your body converts it into the active form that fights the virus.
What makes Tenofovir Alafenamide special compared to the older drug Tenofovir Disoproxil Fumarate (TDF/Viread) is that it delivers the active drug more efficiently to cells, which means a lower dose (just 25 mg once daily) with fewer side effects on kidneys and bones.
To learn more about how this medication works in your body, check out our guide on how Tenofovir Alafenamide works.
There are several reasons why you might be struggling to find Tenofovir Alafenamide at your local pharmacy right now. Here are the main factors:
Vemlidy is a brand-name specialty medication that costs approximately $1,500 to $1,800 per month without insurance. Because of this high price point, many retail pharmacies — especially chain pharmacies — don't keep it regularly in stock. The medication has a relatively small patient population compared to drugs like blood pressure pills or diabetes medications, so pharmacies may not find it economical to stock.
Although the FDA has approved the manufacture of generic Tenofovir Alafenamide, no generic version is actually marketed in the United States as of early 2026. This means patients are limited to the brand-name product, which reduces competition and limits supply channels. A generic combination product (Emtricitabine/Tenofovir Alafenamide) received authorization in the European Union in mid-2025, but it hasn't reached the US market yet.
The broader pharmaceutical supply chain has faced ongoing disruptions affecting antiviral medications. While Vemlidy itself hasn't been subject to a formal FDA shortage, some TAF-containing combination products like Biktarvy and Descovy have experienced intermittent supply constraints. These disruptions can create ripple effects that impact pharmacy ordering patterns and inventory decisions for all TAF-based products.
Even when the medication is physically available, insurance hurdles can make it feel impossible to get. Many insurance plans require prior authorization before covering Vemlidy, and some plans implement step therapy, requiring patients to try the older and cheaper Tenofovir Disoproxil Fumarate (TDF) first. These administrative delays can add days or weeks to the process of filling your prescription.
If you're having trouble finding Tenofovir Alafenamide, don't give up. Here are practical steps you can take today:
Medfinder lets you search for pharmacies that currently have Tenofovir Alafenamide in stock near your location. Instead of calling pharmacy after pharmacy, you can check availability in seconds.
Independent pharmacies and specialty pharmacies often have more flexibility in their ordering. They may be more willing to order Vemlidy for you or may already stock it for their hepatitis B patients. For a step-by-step approach, read our guide on how to find Tenofovir Alafenamide in stock near you.
If you truly cannot find Tenofovir Alafenamide, your doctor may be able to prescribe an alternative medication such as Entecavir (Baraclude) or Tenofovir Disoproxil Fumarate (Viread). These aren't identical to TAF, but they treat the same condition.
If cost is the barrier, Gilead Sciences offers a co-pay assistance program that can reduce your out-of-pocket cost to as little as $0 per month. Call 1-855-769-7284 to learn more. For uninsured patients, Gilead's Advancing Access program may provide the medication for free. Read more in our post on how to save money on Tenofovir Alafenamide.
Finding Tenofovir Alafenamide in 2026 can be challenging, but it's far from impossible. The key is knowing where to look and what resources are available to you. Whether it's using Medfinder to locate pharmacies with stock, exploring specialty pharmacies, or working with your doctor on alternatives, there are real solutions.
Your hepatitis B treatment is too important to let pharmacy availability stand in the way. Stay proactive, use the tools available, and don't hesitate to reach out to your healthcare team for support.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
